Here are the most important news, trends and analysis that investors need to start their trading day:

  1. Nasdaq futures soar as stocks look to get back on track
    The Nasdaq MarketSite in New York.

Michael Nagle | Bloomberg | Getty Images

Nasdaq Futures Contracts rebounded nearly 2% on Thursday, boosted by a 14% rise in shares of parent Facebook Metaplatforms on better than expected earnings. Bond yields rose as data showed US economic growth slowed in the first quarter. After the bell on Thursday, megatech continues to lead corporate America with quarterly results like Apple and Amazon must account.

The tech-heavy index, already in a bear market, closed Wednesday at its weak for the yeara day after its worst single-session selloff since September 2020.
the Dow Jones Industrial Average and the S&P500 both were expected to open higher on Thursday after ending the previous session with modest gains. The S&P 500 was still in correction.
The Dow was just below the 10% or more correction threshold from recent highs.
Some movers before commercialization: Teladoc 44% crater after reporting shortfall; South West Airlines rose more than 4% after issuing an optimistic outlook; and Ford rose 1.5% after slightly beating earnings and revenue expectations.

  1. Economic growth declines in the first quarter, gains were expected
    The reference 10-year Treasury yield pink thursday, trading around 2.88%after the government announced that the US economy contracted 1.4% in the first trimester. Economists were expecting growth of 1%. Initial jobless claims for the week ended April 23 were 180,000, in line with estimates. the Federal Reserve will pay close attention to the reports as he seeks a sweet spot to aggressively raise interest rates to fight inflation without closing the door on economic growth.
  2. Facebook pounces on beaten gains; Twitter up on user hit
    A new video from Inspired by Iceland pushes the experience of life through the “metaverse,” as Mark Zuckerberg described it when rebranding from Facebook to Meta on Thursday, October 28, 2021.

Michael Nagle | Bloomberg | Getty Images

Metaplatformsformerly named Facebook, reported mixed results in the first quarter after the closing bell on Wednesday. However, while revenue faltered, key engagement metrics were better than expected, as were earnings. During the call, management provided very encouraging comments on spend, monetization, and longer-term profit potential. They said they also expect revenue growth to reaccelerate over time. Despite surging to around $199 per share in the pre-market, such a level would still keep Meta Platforms down more than 40% for the year.

In this photo illustration, the Twitter logo is displayed on the phone screen, with Elon Musk’s Twitter account in the background. Twitter has been inundated with user reports of high-profile accounts losing thousands of followers in the hours after Tesla CEO Elon Musk announced he was buying the network. social.

Images by Sheldon Cooper/SOPA | Light flare | Getty Images

Twitter Published first quarter profit before the opening bell on Thursday, in what may be one of its last reports as a public company after the social media network’s board agreed to sell to Elon Musk for $44 billion. Twitter shares rose 1% to around $49 apiece premarket, but that’s below Musk’s cash offer of $54.20 per share. Twitter said monetizable daily active users exceeded estimates in the first quarter, but overall revenue was slightly below expectations.

  1. Dow components report strong earnings, only two stocks up
    Two of the three components of the Dow Jones that released quarterly results Thursday morning saw their stocks rise in premarket trading.

McDonald’s was to open 2% higher after delivery income above expectationsfueled by price increases in the United States and strong growth in international sales.
caterpillar was expected to open 2% lower despite earnings and revenue, with help from increased construction activity and rising commodity prices leading to more mining.
Merck was expected to open around 2% after beat on the top and bottom linesaided by the strength of its cancer treatment Keytruda, its HPV vaccine Gardasil and its oral antiviral Covid Molnupiravir.

  1. Eli Lilly’s Obesity Drug Showed Average Weight Loss of 50 Pounds in One Study
    An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey on March 5, 2021.

Mike Segar | Reuters

Eli Lily shares jumped 4% in pre-market Thursday, shortly after publish promising data from a 72-week trial of his obesity drug tirzepatide. Participants lost up to 22.5% of their body weight, or about 52 pounds. Sixty-three percent of participants taking tirzepatide achieved a weight reduction of at least 20%. Also before the bell on Thursday, Lilly reported better-than-expected quarterly earnings and revenue. The drugmaker lowered its full-year profit forecast but raised its revenue outlook.

—CNBC Samantha Subin, Hannah Miao, Sarah Min, Jeff Cox, Zev Fima, lauren feiner and Dom Chu contributed to this report.

— Register now for the CNBC Investing Club to follow Jim Cramer’s every stock market move. Follow the evolution of the market like a pro on CNBC Pro.

Leave a Reply

Your email address will not be published.